|
62. Application of dynamic and static light scattering for size and shape characterization of small extracellular nanoparticles in plasma and ascites of ovarian cancer patientsKsenija Kogej, Darja Božič, Borut Kobal, Maruša Herzog, Katarina Černe, 2021, izvirni znanstveni članek Ključne besede: extracellular vesicles, extracellular nanoparticles, ovarian cancer, dynamic light scattering, static light scattering, particle size, particle shape
Celotno besedilo (datoteka, 1,98 MB) Gradivo ima več datotek! Več... |
|
64. Diagnostic and therapeutic values of angiogenic factors in endometrial cancerLuka Roškar, Irena Roškar, Tea Lanišnik-Rižner, Špela Smrkolj, 2022, pregledni znanstveni članek Ključne besede: endometrial cancer, angiogenesis, biomarkers, angiogenic factors, anti-angiogenic therapy
Celotno besedilo (datoteka, 1,07 MB) Gradivo ima več datotek! Več... |
65. Overview of immune checkpoint inhibitors in gynecological cancer treatmentBoštjan Pirš, Erik Škof, Vladimir Smrkolj, Špela Smrkolj, 2022, pregledni znanstveni članek Ključne besede: immune check-point inhibitor, biomarker, endometrial cancer, ovarian cancer, uterine cervical cancer, vulvar cancer, treatment response prediction
Celotno besedilo (datoteka, 731,71 KB) Gradivo ima več datotek! Več... |
66. Dual effect of combined metformin and 2-deoxy-D-glucose treatment on mitochondrial biogenesis and PD-L1 expression in triple-negative breast cancer cellsJernej Repas, Mateja Zupin, Maja Vodlan, Peter Veranič, Boris Gole, Uroš Potočnik, Mojca Pavlin, 2022, izvirni znanstveni članek Ključne besede: protein N-glycosylation, ER stress, AMPK, PD-1/PD-L1 axis, anchorage-independence, metformin, 2-deoxy-D-glucose, triple-negative breast cancer, T cells, mitochondrial biogenesis, triple negative breast neoplasms, T-lymphocytes, deoxyglucose, organelle biogenesis
Celotno besedilo (datoteka, 5,36 MB) Gradivo ima več datotek! Več... |
67. AKR1B1 as a prognostic biomarker of high-grade serous ovarian cancerMarko Hojnik, Nataša Kenda Šuster, Špela Smrkolj, Damjan Sisinger, Snježana Frković-Grazio, Ivan Verdenik, Tea Lanišnik-Rižner, 2022, izvirni znanstveni članek Ključne besede: high-grade serous ovarian cancer, immunohistochemistry, survival, prognosis, biomarker, aldo-keto reductase family 1 member B1 (AKR1B1), aldo-keto reductase family 1 member B10 (AKR1B10), resistance
Celotno besedilo (datoteka, 6,42 MB) Gradivo ima več datotek! Več... |
68. Identifying the steps required to effectively implement next-generation sequencing in oncology at a national level in EuropeDenis Horgan, Tanja Čufer, 2022, izvirni znanstveni članek Ključne besede: clinical standardization, equitable reimbursement, European Alliance for Personalised Medicine, Europe’s Beating Cancer Plan, evidence generation, governance, molecularly guided treatment options, next-generation sequencing, stakeholder awareness and education, testing infrastructure
Celotno besedilo (datoteka, 2,39 MB) Gradivo ima več datotek! Več... |
69. Physiological concentrations of Cimicifuga racemosa extract do not affect expression of genes involved in estrogen biosynthesis and action in endometrial and ovarian cell linesMaša Sinreih, Klara Gregorič, Kristina Gajser, Tea Lanišnik-Rižner, 2022, izvirni znanstveni članek Ključne besede: endometrial cancer, Cimicifuga racemosa, ovarian cancer, steroid transporters
Celotno besedilo (datoteka, 5,66 MB) Gradivo ima več datotek! Več... |
70. Commercially available molecular tests for human papillomavirusesMario Poljak, Anja Oštrbenk Valenčak, G. Gimpelj Domjanič, Lan Xu, Marc Arbyn, 2020, pregledni znanstveni članek Ključne besede: cervical cancer, human papillomaviruses, commercial tests, HPV, screening
Celotno besedilo (datoteka, 901,18 KB) Gradivo ima več datotek! Več... |
